. Characterization of heterobifunctional adaptor assembly on a solid support and in solution 7 PrA(G,L) molecules (1mg/ml in PBS) were activated by EDC and sulfo-NHS (at 1:100:100 protein:EDC:sulfo-NHS molar ratio) for 15 min, then passed through a NAP-5 desalting column to remove excess EDC and sulfo-NHS. Activated PrA(G,L) were added to a monomeric avidin column at 6:1 biotin-PEG-NH 2 to PrA(G,L) molar ratio and incubated for 2 hours at room temperature. Controls were assembled without anti-CD3 antibody for PBMCs and anti-Her2 antibody for SKBR3 cells.
PBMCs and SKBR3 cells without treatment were used as a reference. Flow cytometry was performed with FACScan in Flow Cytometry Core Lab at the University of Washington. 
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